Edap Tms (NASDAQ:EDAP) Coverage Initiated by Analysts at StockNews.com

StockNews.com started coverage on shares of Edap Tms (NASDAQ:EDAP) in a research note released on Tuesday morning. The firm issued a hold rating on the medical equipment provider’s stock.

Edap Tms Stock Up 2.0 %

EDAP opened at $2.51 on Tuesday. Edap Tms has a twelve month low of $2.00 and a twelve month high of $8.50. The company has a quick ratio of 1.46, a current ratio of 2.18 and a debt-to-equity ratio of 0.08. The company has a 50-day moving average price of $2.41 and a 200 day moving average price of $2.65. The company has a market cap of $93.09 million, a PE ratio of -3.86 and a beta of 0.36.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of EDAP. Parkman Healthcare Partners LLC acquired a new position in shares of Edap Tms during the 3rd quarter worth about $395,000. Jane Street Group LLC raised its position in shares of Edap Tms by 174.7% during the 4th quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider’s stock worth $69,000 after purchasing an additional 73,361 shares during the last quarter. Schonfeld Strategic Advisors LLC raised its position in shares of Edap Tms by 48.5% during the 4th quarter. Schonfeld Strategic Advisors LLC now owns 160,800 shares of the medical equipment provider’s stock worth $355,000 after purchasing an additional 52,500 shares during the last quarter. Millennium Management LLC raised its holdings in Edap Tms by 218.5% in the 4th quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider’s stock valued at $108,000 after acquiring an additional 33,558 shares during the last quarter. Finally, BNP Paribas Financial Markets raised its holdings in Edap Tms by 111.5% in the 4th quarter. BNP Paribas Financial Markets now owns 48,650 shares of the medical equipment provider’s stock valued at $108,000 after acquiring an additional 25,650 shares during the last quarter. Institutional investors and hedge funds own 62.74% of the company’s stock.

About Edap Tms

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.